Long-term treatment & DDI implications in the management of CAT
29 November 2022 – 18:00-19:00 CET Speakers: Luis Jara Palomares, Hans-Peter Lipp, Tzu-Fei Wang Marc Carrier will...
Most Read
A new webinar is coming: “Long-term treatment & DDI implications in the management of CAT”
29 November 2022 – 18:00-19:00 CET Speakers: Luis Jara Palomares, Hans-Peter Lipp, Tzu-Fei Wang Marc Carrier will...
PODCAST. Drug-drug interactions: Implications for anticoagulation use in patients with cancer
Cancer patients have an increased risk of VTE by at least 12-fold, and cancer therapies increase the risk of VTE by a...
Venous thromboembolism in patients with solid tumors: the Italian Association of Medical Oncology (AIOM) guidelines 2019
The latest guidelines for venous thromboembolism in patients with solid tumors from the Italian Association of Medical...
Cancer genetic alterations and risk of venous thromboembolism
During the 11th ICTHIC, Simon Mantha talked about the relationship between genetic cancer alteration and the risk of...
A novel biomarker for chemotherapy-associated venous thromboembolism
Ovarian cancer patients are at high risk of venous thromboembolism (VTE). More than 80% of women present with a...
Cancer-Associated Thrombosis: Updates and Controversies
In this webinar, our speakers Prof. Anna Falanga, Prof. Alok A Khorana, and Prof. Benjamin Brenner talked about the...
Recording available for the webinar “Updates in Cancer-Associated Thrombosis”
You can now watch the recording of “updates in cancer-associated thrombosis” webinar. Check...
Benjamin Brenner
Benjamin Brenner Director, Hematology and Bone Marrow Transplantation Institute – Director, Division of Internal...
The Management of Cancer-Associated Thrombosis: Are We at a Crossroad?
During this webinar, our three speakers, Professor Anna Falanga, Dr. Florian Scottè, and Dr. Luis Jara Palomares,...